L. Mary Smith - 30 Jun 2023 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role
Chief Development Officer
Signature
/s/ Francis I. Perier, Jr. as Attorney-in Fact
Issuer symbol
SWTX
Transactions as of
30 Jun 2023
Net transactions value
$0
Form type
4
Filing time
05 Jul 2023, 16:06:22 UTC
Previous filing
10 Jan 2023
Next filing
08 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWTX Common Stock Award +5,720 +2.7% 217,939 30 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty three percent (33%) to vest on June 30, 2024, another thirty three percent (33%) to vest on June 30, 2025 and the remaining thirty four percent (34%) to vest on June 30, 2026, such that the restricted stock awards are fully vested on June 30, 2026.